(4-chloro-3-(4-methylpiperazine-1-carbonyl)phenyl)boronic acid

Catalog No. :
ACUUTQ966
CAS No. :
1704073-98-2
Molecular Formula :
C12H16BClN2O3
Molecular Weight :
282.54

IUPAC Name:(4-chloro-3-(4-methylpiperazine-1-carbonyl)phenyl)boronic acid

(4-chloro-3-(4-methylpiperazine-1-carbonyl)phenyl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$428.00Login to see priceInquiryInquiry
1g98%$1073.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-chloro-3-(4-methylpiperazine-1-carbonyl)phenyl)boronic acid
IUPAC Name(4-chloro-3-(4-methylpiperazine-1-carbonyl)phenyl)boronic acid
MDL No.MFCD28384311
Molecular FormulaC12H16BClN2O3
Molecular Weight282.54
SMILESO=C(C1=CC(B(O)O)=CC=C1Cl)N2CCN(C)CC2
InChI KeyPDDNKGPQOBJEIN-UHFFFAOYSA-N
Synonym(4-chloro-3-(4-Methylpiperazine-1-carbonyl)phenyl)boronic acid;Boronic acid, B-[4-chloro-3-[(4-methyl-1-piperazinyl)carbonyl]phenyl]-
CAS No.1704073-98-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACUUTQ966 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  2. Plus
  3. ACBHJP786 route compound structure diagram
    ACBHJP786913835-32-2 In Stock
  4. Then
  5. ACUUTQ966 route product structure diagram
    ACUUTQ9661704073-98-2
Inquiry

2. ACUUTQ966 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUUTQ966 route product structure diagram
    ACUUTQ9661704073-98-2
Inquiry

Comments (0)